Is semiconductors alone not enough? Changes to watch in the second half market

Is semiconductors alone not enough? Changes to watch in the second half market | Myeong Min-jun, Park Ga-yeong, Lee Jae-gyu SK Securities PB Assistant Manager [Stock Beginner Rescue Team]
Watch on YouTube ↗  |  August 07, 2026 at 11:14  |  45:57  |  3PRO TV (삼프로TV)
Speakers
Lee Jae-kyu — PB Deputy Manager, SK Securities

Summary

SK Securities PB Assistant Manager Lee Jae-gyu expects a market shift from semiconductor dominance to stock-picking. He recommends reducing Samsung Electronics and SK hynix, and turning toward KOSDAQ, biotech, robots, secondary batteries, and Hyundai Motor Group. He also sees Korean equities outperforming US equities in H2.

  • KOSDAQ index seen reaching 1,000 by year-end, outperforming KOSPI.
  • Semiconductor stocks like Samsung and SK hynix should be trimmed to 20-30% as H2 may disappoint.
  • Biotech named top sector pick: Samsung Biologics, Celltrion, Alteogen, DND Pharmatech, Hanall Biopharma.
  • Robots (Robotis) and secondary batteries (Samsung SDI preferred) are next in ranking.
  • Hyundai Motor Group offers value and robot revaluation potential.
  • Naver and LG Electronics are expected to rebound after being heavily oversold.
  • Korean equities are favored over US equities, with the trend just beginning.
  • Semiconductor equipment stocks are avoided due to weak fundamentals and flow-driven moves.
Ideas
Lee Jae-kyu PB Deputy Manager, SK Securities 3:08
Reduce Samsung and SK hynix exposure.
Semiconductor stocks like Samsung Electronics and SK hynix may underperform in the second half. The market has shifted from a semiconductor-dominated rally in H1 to a stock-picking environment. Having too much exposure to these two stocks could feel left out. Recommendation is to reduce semiconductor weighting to 20-30%, with 40% maximum only if cost basis is low. The first bounce in semiconductors has already occurred, and a further pullback would be a buying opportunity, but if they fail to rebound next week, aggressively cut position.
Lee Jae-kyu PB Deputy Manager, SK Securities 8:27
KOSDAQ to reach 1000 outperforming KOSPI.
The KOSDAQ index will reach 1,000 points by year-end, outperforming KOSPI. The first bounce from oversold levels is over, but after a consolidation, KOSDAQ has more upside. KOSPI needs to break above its prior high to reach 10,000, while KOSDAQ already retraced from above 1,000, making the upside path faster. If KOSDAQ holds up for another month, the trend has changed and strength will continue into early next year.
Lee Jae-kyu PB Deputy Manager, SK Securities 22:08
Korean equities to outperform US equities.
Korean equities will outperform US equities. The US has outperformed for over 10 years, but since last year Korea has been stronger and this is not temporary. When social media interest in US stocks peaks, it often signals a top, and Korean market becomes much stronger.
Lee Jae-kyu PB Deputy Manager, SK Securities 22:08
Korean equities to outperform US equities.
Korean equities will outperform US equities. The US has outperformed for over 10 years, but since last year Korea has been stronger and this is not temporary. When social media interest in US stocks peaks, it often signals a top, and Korean market becomes much stronger.
Lee Jae-kyu PB Deputy Manager, SK Securities 27:47
Buy secondary batteries on oversold bounce.
Secondary battery stocks are a buy now because they have been extremely oversold and fundamentals are improving. Samsung SDI turned to profit after seven quarters, LG Energy Solution after three, and LNF reported solid earnings. Although valuations are not cheap (50x P/E for cells), stocks can rise on supply-demand flows as money rotates from semiconductors into other sectors. Samsung SDI has better stock momentum and is preferred over LG Energy Solution. US regulation against China further benefits Korean battery companies.
Lee Jae-kyu PB Deputy Manager, SK Securities 33:02
Robotis strong robotics play.
Robotics sector is the second most attractive after biotech. He specifically bought Robotis after selling Hyundai Motor, signaling strong conviction. Robotis is a pure-play robotics company that should benefit from the growing robot theme.
Lee Jae-kyu PB Deputy Manager, SK Securities 36:05
Naver and LG Electronics likely to rebound.
Naver and LG Electronics have pulled back sharply after the Jensen Huang visit like a decalcomania, but they are likely to receive growth revaluation and rally again. They are part of the broader rotation into beaten-down quality names.
Lee Jae-kyu PB Deputy Manager, SK Securities 41:20
Hyundai Motor attractive value-robot play.
Hyundai Motor Group is attractive as a value-plus-robot play. Hyundai Motor trades at about 11x P/B versus global automakers at 12x, so there is upside. The recent pullback after the Jensen Huang visit was excessive, and growth revaluation could come from the robot business as well, making the group a good rebound candidate among heavily-sold-off sectors.
Lee Jae-kyu PB Deputy Manager, SK Securities 43:08
Biotech stocks top pick for H2.
Korean biotech and pharmaceutical stocks are the top sector pick for the second half. Samsung Biologics and Celltrion are stable, large-cap options; Alteogen offers higher growth and volatility; DND Pharmatech presents a buying opportunity after a recent plunge that was not a real negative; Hanall Biopharma is a KOSPI-listed biotech worth watching. The sector benefits from rotation away from overbought semiconductors and from a market environment where many oversold names rebound.
Up Next

This 3PRO TV (삼프로TV) video, published August 07, 2026, features Lee Jae-kyu discussing 005930.KS, 000660.KS, KODEX KOSDAQ 150 ETF, KODEX 200 ETF, SPY, 006400.KS, 108490.KQ, 066570.KS, 035420.KS, 005380.KS, 046310.KQ, 068270.KS, 196170.KQ, DND Pharmatech, 207940.KS. 9 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Jae-kyu  · Tickers: 005930.KS, 000660.KS, KODEX KOSDAQ 150 ETF, KODEX 200 ETF, SPY, 006400.KS, 108490.KQ, 066570.KS, 035420.KS, 005380.KS, 046310.KQ, 068270.KS, 196170.KQ, DND Pharmatech, 207940.KS